Phase 4 Fibromyalgia Trial, Recruiting NCT04704297 Sponsor: Madigan Army Medical Center Condition: Fibromyalgia
Back to Fibromyalgia

Phase 4 Fibromyalgia Trial, Recruiting

NCT04704297
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have at least one trigger point (a tight, tender knot of muscle) in the muscles alongside their lower spine
  • People with ongoing (chronic) low back pain whose current flare-up is meaningfully worse than their usual baseline pain level, as measured on a standard pain scale

Who may not be able to join:

  • People who are allergic to, or unable to take, the medications being used in the study
  • People who have developed new weakness, numbness, or loss of feeling in their legs
  • People with a known active cancer that has spread to the bones of the spine
  • People with a confirmed fracture in the spine, lower back, hip area, or sacral region
  • People with a history of fibromyalgia, rheumatoid arthritis, or ankylosing spondylitis (a type of spinal inflammatory disease)
  • People who are currently taking blood-thinning medication
  • People who have a skin infection (cellulitis) over the area where an injection would be given
  • People who have had surgery on the spine, hip, or pelvis within the past 6 months
  • People who have already received trigger point injections for this current episode of back pain
  • People whose pain travels down the back of the leg all the way to the heel (sciatica)
  • People whose pain has a clearly identified cause other than muscle or musculoskeletal pain
  • People who currently have a fever
  • People who are pregnant
  • People who are unable to understand English or cannot give informed consent for any reason, including difficulty understanding instructions, risks, or benefits — or people in certain groups such as prisoners, students, military cadets or midshipmen, resident physicians, or wounded warriors (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Joshua J Oliver, MD, Madigan AMC

Phone: (360) 393-9024

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Madigan Army Medical Center
Registry
ClinicalTrials.gov
Start date
28 December 2020
Est. completion
1 July 2022

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pain reduction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov